Reversal of diabetes-induced depletion of bone marrow (BM)–resident LSK cells and impairment of proliferation by ANG-(1-7) treatment. Reversal of diabetes-induced.

Slides:



Advertisements
Similar presentations
Brent Hoffman. HOXA9 is one of the HOX transcription factors regulating Anterior to Posterior patterning in early development.
Advertisements

Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration by Ayako Nakamura-Ishizu,
Orexin: A possible link between diabetes and depression?
Circulating Monocytes in between the Gut and the Mind
CDK2 is highly expressed in colon cancer cells and curcumin selectively suppresses HCT116 cell proliferation. CDK2 is highly expressed in colon cancer.
Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells by Toshihiko Tanno, Yiting Lim, Qiuju.
Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1 by Ingrid G. Winkler,
by Jonathan Hoggatt, Pratibha Singh, Janardhan Sampath, and Louis M
TLR5 signaling in murine bone marrow induces hematopoietic progenitor cell proliferation and aids survival from radiation by Benyue Zhang, Damilola Oyewole-Said,
Insulin content of isolated pancreas and islet morphology.
INT-767 treatment prevents the increase in renal HIF and Glut1 expression and ER stress in diabetic DBA/2J mice. INT-767 treatment prevents the increase.
Fig. 6. Treatment with a DLK inhibitor is neuroprotective and reverses stress-induced gene expression changes. Treatment with a DLK inhibitor is neuroprotective.
Circulating Monocytes in between the Gut and the Mind
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia by Parvathi Ranganathan, Xueyan Yu, Caroline Na, Ramasamy Santhanam, Sharon Shacham,
Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells by Angela Colmone, Maria Amorim, Andrea L.
Everolimus Inhibits SMC Proliferation Through Transcriptional Repression of Telomerase (A) Cell proliferation assay in primary murine vascular smooth muscle.
Immunohistochemical analysis.
Change in random blood glucose level, body weight, and intraperitoneal glucose tolerance test (IPGTT) in streptozotocin (STZ)-induced diabetic mice. Change.
Imetelstat, a telomerase inhibitor, is capable of depleting myelofibrosis stem and progenitor cells by Xiaoli Wang, Cing Siang Hu, Bruce Petersen, Jiajing.
Volume 10, Issue 4, Pages (April 2012)
Granulocyte Colony-Stimulating Factor Induces Osteoblast Inhibition by B Lymphocytes and Osteoclast Activation by T Lymphocytes during Hematopoietic Stem/Progenitor.
Viability and function of mouse pancreatic cell line.
by Yue Wei, Hong Zheng, Naran Bao, Shan Jiang, Carlos E
Fig. 5 ALRN-6924 shows robust antileukemic activity in primary AML cells and in vivo. ALRN-6924 shows robust antileukemic activity in primary AML cells.
Treatment with MI-773 causes changes in p53 status.
BTG2 regulates gluconeogenic gene expression in diabetic mouse models
1018-NT-β-cell clusters protect mice from STZ-induced diabetes.
Pancreatic β-cell proliferation.
Nrf2−/− mice had higher TGF-β1 transcription and FN expression.
Cell proliferations, ROS production, and ATP levels in HASMCs cultured under high-glucose condition. Cell proliferations, ROS production, and ATP levels.
PMPs survive STZ cytotoxicity and produce larger colonies with a higher yield of insulin+ progeny. PMPs survive STZ cytotoxicity and produce larger colonies.
Nrf2−/− mice suffered greater renal damage by STZ compared with Nrf2+/+ mice. Nrf2−/− mice suffered greater renal damage by STZ compared with Nrf2+/+ mice.
IL-6 inhibits insulin-induced formation of p85/IRS-1 complexes.
E11 pancreas cultured for 6 days in the presence of morpholine-ring antisense against GIP, GIPR, or control. E11 pancreas cultured for 6 days in the presence.
Effects of pterosin A on serum levels of lipid, blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), and alanine aminotransferase (ALT)
GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. GLP-1 and gastrin combination therapy restores normoglycemia in NOD mice. Beginning.
A: Chemical structure of pterosin A
VIP treatment decreased the number of apoptotic cells and increased cell proliferation. VIP treatment decreased the number of apoptotic cells and increased.
GLP-1 and gastrin combination therapy induces immunoregulatory cell activity in NOD mice. GLP-1 and gastrin combination therapy induces immunoregulatory.
Npas4 is a stress-induced factor in pancreatic β-cells.
An anti-BTC neutralizing antibody and a metalloproteinase inhibitor suppress GLP-1-induced DNA synthesis in INS(832/13) cells. [3H]thymidine incorporation.
Reversal of diabetic impairments in the blood flow recovery and neovascularization of ischemic areas by ANG-(1-7): A: Representative laser Doppler images.
d-PA, unlike n-PA, impairs EPC functions.
Effect of GSK-3 inhibitors on basal and insulin-stimulated glucose uptake in human muscle cells. Effect of GSK-3 inhibitors on basal and insulin-stimulated.
Fig. 1 Effects of protein phosphatase 2A–activating drug and protein phosphatase 2A–inhibiting drug in chronic myeloid leukemia. Effects of protein phosphatase.
Effects of rhein on FBG (A) and glucose intolerance (B) in db/db mice.
Persistence of hyperplastic islets lacking proliferating and apoptotic cells in some RIP7-rtTA × tet-Tag mice. Persistence of hyperplastic islets lacking.
TFAP2A interacts with HIF-1α and regulates VEGF expression and cell proliferation. TFAP2A interacts with HIF-1α and regulates VEGF expression and cell.
TH-302 has antileukemia activity in an in vivo primary AML xenograft murine model. TH-302 has antileukemia activity in an in vivo primary AML xenograft.
Leukemic blasts express a “hypoxia signature
Figure 5. Hematopoietic cell specific Atg5 deficiency results in aberrant proliferation and mitochondrial dysfunction in hematopoietic cells. (A) Apoptosis.
Effect of HA on hematopoietic recovery in tumor-bearing mice.
Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.
Colony-forming capacity of CD34+ cells with and without CLL-1 expression. Colony-forming capacity of CD34+ cells with and without CLL-1 expression. CD34+
Drug sensitivities of IGROV1 cells to AGF94 and PMX at leucovorin (LCV) concentrations of 2 and 25 nmol/L. Drug sensitivities of IGROV1 cells to AGF94.
The effect of IAA and glycyrrhizin (Gc) on growth of human melanoma cells. The effect of IAA and glycyrrhizin (Gc) on growth of human melanoma cells. A,
Targeting Fat to Prevent Diabetes
In vivo AraC treatment does not induce any consistent changes in CD34+/−CD38+/− phenotypes nor in quiescent leukemic cells but increases apoptotic cell.
Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma cells. Effect of GSK3β inhibition on cell survival and proliferation of glioblastoma.
PC-3 (A) and DU-145 (B) cell survival analysis by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay following 48 h treatment with 0 μmol/L.
ESKM treatment does not affect leukocyte or HSC counts in HLA-A
Systemic reovirus treatment targets disseminated human myeloma in vivo
Osteoactivin expression is required for the invasive phenotype of in vivo selected bone metastatic 4T1 breast cancer cells. Osteoactivin expression is.
The effects of 5α-dihydrotestosterone and growth factors (insulin-like growth factor I and epidermal growth factor) on LNCaP cell proliferation. The effects.
Pdcd4 expression inhibits AP-1 transactivation.
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
PI3Kγ controls macrophage PDGF expression to promote PDAC tumor cell invasion. PI3Kγ controls macrophage PDGF expression to promote PDAC tumor cell invasion.
Constitutive expression of JAK3M511I and HOXA9 leads to development of both AML and T-ALL in vivo. Constitutive expression of JAK3M511I and HOXA9 leads.
Effects of inhibitors of PI3K, MEK1, and GSK-3β on visfatin-induced proliferation in HepG2 cells. Effects of inhibitors of PI3K, MEK1, and GSK-3β on visfatin-induced.
ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared with ibrutinib. ARQ 531 improves survival in the Eμ-TCL1 engraftment model compared.
Presentation transcript:

Reversal of diabetes-induced depletion of bone marrow (BM)–resident LSK cells and impairment of proliferation by ANG-(1-7) treatment. Reversal of diabetes-induced depletion of bone marrow (BM)–resident LSK cells and impairment of proliferation by ANG-(1-7) treatment. A and B: The number of BM LSK cells was decreased in STZ-diabetic or db/db mice, which was reversed by ANG-(1-7) treatment (n = 6–8). C and D: The proliferation of cells was determined using a BrdU proliferation assay kit (Roche Bioscience) by using 10,000 cells/well in RPMI 1640 medium for 48 h with or without drug treatments. Proliferation was expressed as a fold increase relative to the effect of mitomycin (1 μmol/L), an inhibitor of proliferation. LSK cells derived from STZ or db/db mice showed decreased proliferation in basal conditions or in response to SDF or VEGF. Proliferation was restored to normal in cells derived from ANG-(1-7)–treated diabetic mice (n = 6). WBCs, white blood cells. Goutham Vasam et al. Diabetes 2017;66:505-518 ©2017 by American Diabetes Association